SCHEMBL24578101

SCHEMBL24578101

Cc1ncc(NC(=O)CCCl)cc1NC(=O)c1cnn2cc(-c3cnn(C)c3)sc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDGFRA P16234 2/20 0.41
▸ CHRM1 P11229 1/20 0.41
▸ HRH3 Q9Y5N1 1/20 0.41
▸ CSF1R P07333 2/20 0.40
▸ KIT P10721 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ IRAK4 Q9NWZ3 1/20 0.34
▸ IKBKE Q14164 1/20 0.33
▸ TBK1 Q9UHD2 1/20 0.33
▸ NTRK1 P04629 4/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33
▸ STING1 Q86WV6 1/20 0.32
▸ CREBBP Q92793 2/20 0.32
▸ RAF1 P04049 1/20 0.32
▸ BRAF P15056 1/20 0.32
▸ LRRK2 Q5S007 1/20 0.32
▸ JAK2 O60674 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29759564 1.00 PDGFRA (0.41) PDGFRACHRM1HRH3CSF1RKIT
SCHEMBL24578740 0.96 CSF1R (0.40) PDGFRACHRM1HRH3CSF1RKIT
SCHEMBL29759578 0.96 CSF1R (0.40) PDGFRACHRM1HRH3CSF1RKIT
SCHEMBL29759824 0.93 ALDH1A1 (0.43) PDGFRACHRM1HRH3CSF1RKIT
SCHEMBL24577074 0.93 ALDH1A1 (0.43) PDGFRACHRM1HRH3CSF1RKIT
SCHEMBL24577629 0.89 IKBKE (0.41) PDGFRACHRM1HRH3CSF1RKIT
SCHEMBL29759547 0.89 IKBKE (0.41) PDGFRACHRM1HRH3CSF1RKIT
SCHEMBL29759755 0.89 KIT (0.42) PDGFRACHRM1HRH3CSF1RKIT
SCHEMBL27185302 0.89 KIT (0.44) PDGFRACHRM1HRH3CSF1RKIT
SCHEMBL29759814 0.88 CHRM1 (0.40) PDGFRACHRM1HRH3CSF1RKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022136509-A1 PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2022-06-30 — — WO disclosed
Send feedback